Clinical Trial Update: Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of RsqVD combination therapy in newly diagnosed multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• RsqVD

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED